You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Claims for Patent: 10,370,460

✉ Email this page to a colleague

Summary for Patent: 10,370,460

Title:	Process for producing functionalized polymers
Abstract:	A method for producing a functionalized polymer, the method comprising the steps of: (i) preparing a bulk polymerization system including a reactive polymer by introducing a lanthanide-based catalyst and a conjugated diene monomer; (ii) adding a heterocyclic nitrile compound the polymerization system including the reactive polymer to prepare polymerization system including a functionalized polymer; and (iii) adding a protic compound to the polymerization system including a functionalized polymer where the ratio of water or protic hydrogen atoms in the protic compound to the lanthanide atoms in the lanthanide-based catalyst is at least 1500 to 1.
Inventor(s):	Kevin Michael MCCAULEY, Timothy Leonard Tartamella, Zachary Aaron Bush
Assignee:	Bridgestone Corp
Application Number:	US15/159,114

Details for Patent 10,370,460

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Kite Pharma Inc.	YESCARTA	axicabtagene ciloleucel	Injection	125643	October 18, 2017	10,370,460	2036-05-19
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.